• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一系列作为凝血酶抑制剂的天然类黄酮:结构-活性关系。

A series of natural flavonoids as thrombin inhibitors: structure-activity relationships.

机构信息

Jiangsu Key Laboratory for TCM Formulae Research, Nanjing University of Chinese Medicine, Nanjing 210046, China.

出版信息

Thromb Res. 2010 Nov;126(5):e365-78. doi: 10.1016/j.thromres.2010.08.006. Epub 2010 Sep 15.

DOI:10.1016/j.thromres.2010.08.006
PMID:20828797
Abstract

A series of natural flavonoids has been evaluated as potential inhibitors of thrombin using the optimized method of thrombin time. Myricetin and quercetin have shown to be the best thrombin inhibitors tested. In order to investigate the thrombin recognition of the most active and selective compounds, a molecular modeling study has been performed using available Protein Data Bank (PDB) structures as receptor models for docking experiments. Structure-activity relationships of flavonoids (SARs) on thrombin would facilitate the design of chemical compounds with higher potency to serve as potential thrombin inhibitors, and provide information for the exploitation and utilization of flavonoids as thrombin inhibitors for thrombotic disease treatment.

摘要

一系列天然类黄酮已被评估为使用优化的凝血酶时间法潜在的凝血酶抑制剂。研究表明,杨梅素和槲皮素是测试过的最好的凝血酶抑制剂。为了研究最有效和选择性的化合物与凝血酶的识别,使用现有的蛋白质数据库(PDB)结构作为受体模型进行了分子建模研究,进行对接实验。凝血酶的黄酮类化合物结构活性关系(SAR)将有助于设计具有更高效力的化合物作为潜在的凝血酶抑制剂,并为开发和利用黄酮类化合物作为抗血栓疾病治疗的凝血酶抑制剂提供信息。

相似文献

1
A series of natural flavonoids as thrombin inhibitors: structure-activity relationships.一系列作为凝血酶抑制剂的天然类黄酮:结构-活性关系。
Thromb Res. 2010 Nov;126(5):e365-78. doi: 10.1016/j.thromres.2010.08.006. Epub 2010 Sep 15.
2
Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors.基于代谢的合成、生物评价及槲皮素 O-甲基化类似物作为凝血酶抑制剂的构效关系分析。
Eur J Med Chem. 2012 Aug;54:210-22. doi: 10.1016/j.ejmech.2012.04.044. Epub 2012 May 14.
3
In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.基于三肽的α-酮杂环作为凝血酶抑制剂的深入研究。S1'亚位点的有效利用及其对基于结构的药物设计的意义。
J Med Chem. 2005 Mar 24;48(6):1984-2008. doi: 10.1021/jm0303857.
4
Flavonoids inhibit the amidolytic activity of human thrombin.类黄酮抑制人凝血酶的酰胺水解活性。
Biochimie. 2006 Sep;88(9):1297-306. doi: 10.1016/j.biochi.2006.04.007. Epub 2006 Apr 27.
5
Study on Structure Activity Relationship of Natural Flavonoids against Thrombin by Molecular Docking Virtual Screening Combined with Activity Evaluation In Vitro.基于分子对接虚拟筛选结合体外活性评价的天然黄酮类化合物抗凝血酶构效关系研究
Molecules. 2020 Jan 20;25(2):422. doi: 10.3390/molecules25020422.
6
Crystal structures of thrombin complexed to a novel series of synthetic inhibitors containing a 5,5-trans-lactone template.凝血酶与一系列含有5,5-反式内酯模板的新型合成抑制剂复合的晶体结构。
Biochemistry. 1999 Jun 22;38(25):7969-77. doi: 10.1021/bi9830359.
7
Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles.用于凝血酶抑制剂支架P1位置的新型基团的基于结构的设计。第2部分:N-乙酰氨基咪唑。
Bioorg Med Chem Lett. 2008 Mar 15;18(6):2062-6. doi: 10.1016/j.bmcl.2008.01.098. Epub 2008 Jan 30.
8
Molecular modeling and 3D-QSAR studies on the interaction mechanism of tripeptidyl thrombin inhibitors with human alpha-thrombin.三肽基凝血酶抑制剂与人α-凝血酶相互作用机制的分子模拟及三维定量构效关系研究
J Med Chem. 1997 Sep 12;40(19):3085-90. doi: 10.1021/jm960309m.
9
Synthesis and SAR of thrombin inhibitors incorporating a novel 4-amino-morpholinone sscaffold: analysis of X-ray crystal structure of enzyme inhibitor complex.含有新型4-氨基吗啉酮骨架的凝血酶抑制剂的合成与构效关系:酶-抑制剂复合物的X射线晶体结构分析
J Med Chem. 2003 Sep 11;46(19):3985-4001. doi: 10.1021/jm0307990.
10
A novel factor Xa inhibitor: structure-activity relationships and selectivity between factor Xa and thrombin.一种新型凝血因子Xa抑制剂:结构-活性关系以及凝血因子Xa与凝血酶之间的选择性
Biochem Biophys Res Commun. 1993 Dec 15;197(2):965-72. doi: 10.1006/bbrc.1993.2573.

引用本文的文献

1
A review of natural compounds to regulate platelet aggregation: molecular mechanism and research advance.调节血小板聚集的天然化合物综述:分子机制与研究进展
Front Pharmacol. 2025 Jun 27;16:1537776. doi: 10.3389/fphar.2025.1537776. eCollection 2025.
2
Virtual screening, ADME prediction, drug-likeness, and molecular docking analysis of Fagonia indica chemical constituents against antidiabetic targets.假木豆化学成分针对抗糖尿病靶点的虚拟筛选、ADME预测、类药性及分子对接分析
Mol Divers. 2025 Apr;29(2):1139-1160. doi: 10.1007/s11030-024-10897-7. Epub 2024 Jul 16.
3
Flavonol and A-type procyanidin-rich extracts of L. flower exhibit anticoagulant activity through direct thrombin inhibition, but do not affect platelet aggregation .
荔枝花中富含黄酮醇和A型原花青素的提取物通过直接抑制凝血酶表现出抗凝活性,但不影响血小板聚集。
Front Pharmacol. 2023 Nov 27;14:1307373. doi: 10.3389/fphar.2023.1307373. eCollection 2023.
4
Plant-Derived Compounds and Extracts as Modulators of Plasmin Activity-A Review.植物源化合物和提取物作为纤溶酶活性调节剂的研究进展。
Molecules. 2023 Feb 9;28(4):1677. doi: 10.3390/molecules28041677.
5
Network Pharmacology and Experimental Validation to Explore the Mechanism of Qing-Jin-Hua-Tan-Decoction Against Acute Lung Injury.基于网络药理学和实验验证探索清金化痰汤抗急性肺损伤的机制
Front Pharmacol. 2022 Jul 8;13:891889. doi: 10.3389/fphar.2022.891889. eCollection 2022.
6
In Vitro Antithrombotic, Hematological Toxicity, and Inhibitor Studies of Protocatechuic, Isovanillic, and -Hydroxybenzoic Acids from (Carr.) Bur.原儿茶酸、香草酸和 - 羟基苯甲酸体外抗血栓形成、血液毒性和抑制剂研究
Molecules. 2022 May 29;27(11):3496. doi: 10.3390/molecules27113496.
7
Improved therapeutic efficacy of quercetin-loaded polymeric nanoparticles on triple-negative breast cancer by inhibiting uPA.通过抑制尿激酶型纤溶酶原激活剂提高载槲皮素聚合物纳米粒对三阴性乳腺癌的治疗效果。
RSC Adv. 2020 Sep 17;10(57):34517-34526. doi: 10.1039/d0ra04231e. eCollection 2020 Sep 16.
8
Inhibition of human thrombin by the constituents of licorice: inhibition kinetics and mechanistic insights through and studies.甘草成分对人凝血酶的抑制作用:通过……和……研究的抑制动力学及机制洞察
RSC Adv. 2020 Jan 22;10(7):3626-3635. doi: 10.1039/c9ra09203j.
9
Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19.植物药在 COVID-19 住院患者凝血功能障碍管理中的潜在临床应用。
Phytother Res. 2022 May;36(5):1884-1913. doi: 10.1002/ptr.7408. Epub 2022 Feb 11.
10
Screening of Potential Thrombin and Factor Xa Inhibitors from the Danshen-Chuanxiong Herbal Pair through a Spectrum-Effect Relationship Analysis.基于谱效关系分析从丹参-川芎药对中筛选潜在的凝血酶和因子 Xa 抑制剂。
Molecules. 2021 Dec 1;26(23):7293. doi: 10.3390/molecules26237293.